Cuts to seniors' prescription drug help and GOP bills to repeal anti-fraud laws will hike medicine costs and lead to worse health outcomes.
It seems there is an all-out assault on prescription drug programs in Maine Governor LePage's budget as well as in bills pending before the Health and Human Services (HHS) Committee. These proposals certainly will help the bottom line of large pharmaceutical concerns, but they harm over 40,000 seniors who rely on state assistance to purchase prescription drugs, and repeal important pricing protections for consumers and taxpayers.
Its hard to believe that legislators who campaigned for strong financial oversight and against waste would support repealing a law that bans kickbacks and requires rebates be passed through to consumers, but that's exactly what Maine bill LD 1116 would do. Another bill, LD 719,will limit doctor, patient, and government access to independent information on prescription drug effectiveness, costs, and money spent on drug advertising, and make it harder to audit drug company pricing information. Read more »